We are live on ! Find out more
BNGO icon

Bionano Genomics
BNGO

20 hedge funds and large institutions have $1.98M invested in Bionano Genomics in 2020 Q2 according to their latest regulatory filings, with 10 funds opening new positions, 6 increasing their positions, 0 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

400% more first-time investments, than exits

New positions opened: 10 | Existing positions closed: 2

311% more capital invested

Capital invested by funds: $482K → $1.98M (+$1.5M)

67% more funds holding

Funds holding: 12 → 20 (+8)

0% more ownership

Funds ownership: 0% → 0.01% (+0%)

Holders
20
Holders Change
+8
Holders Change %
+66.67%
% of All Funds
0.41%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
10
Increased
6
Reduced
–
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
SCM
Sio Capital Management
New York
+$647K
2
Bank Julius Baer & Co
Bank Julius Baer & Co
Switzerland
+$124K
3
Citadel Advisors
Citadel Advisors
Florida
+$92.2K
4
Vanguard Group
Vanguard Group
Pennsylvania
+$64K
5
UBS Group
UBS Group
Switzerland
+$61.5K

Top Sellers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
-$12K
Name Holding Trade Value Shares
Change 		Change in
Stake
SCM
1
Sio Capital Management
New York
$789K +$647K +2,577 New
Bank Julius Baer & Co
2
Bank Julius Baer & Co
Switzerland
$382K +$124K +495 +66%
Vanguard Group
3
Vanguard Group
Pennsylvania
$181K +$64K +255 +76%
Geode Capital Management
4
Geode Capital Management
Massachusetts
$163K +$30.9K +123 +30%
Citadel Advisors
5
Citadel Advisors
Florida
$112K +$92.2K +367 New
UBS Group
6
UBS Group
Switzerland
$101K +$61.5K +245 +285%
Barclays
7
Barclays
United Kingdom
$61K +$50.2K +200 New
BCM
8
Bayesian Capital Management
New York
$51K +$41.7K +166 New
Northern Trust
9
Northern Trust
Illinois
$32K +$15.3K +61 +145%
Bank of New York Mellon
10
Bank of New York Mellon
New York
$24K – – –
TWM
11
Triton Wealth Management
Arizona
$23K +$12.6K +50 New
TRCT
12
Tower Research Capital (TRC)
New York
$21K +$17.1K +68 New
LDFR
13
Lehman & Derafelo Financial Resources
Pennsylvania
$18K +$14.8K +59 New
Victory Capital Management
14
Victory Capital Management
Texas
$7K +$1.26K +5 +29%
PAG
15
Private Advisor Group
New Jersey
$7K +$5.53K +22 New
TSS
16
Two Sigma Securities
New York
$6K +$4.77K +19 New
Osaic Holdings
17
Osaic Holdings
Arizona
$3K +$2.01K +8 New
AF
18
Advisornet Financial
Minnesota
$1K – – –
BlackRock
19
BlackRock
New York
– -$12K -46 Closed

BNGO Hedge Fund Activity: Q2 2020 in Review

20 of the 4,878 institutional investors tracked by Wall St. Rank reported a position in Bionano Genomics (BNGO) for Q2 2020, worth a combined $1.98M — up 311% from $482K a quarter earlier.

Buyers outnumbered sellers: 10 funds opened new BNGO positions and 2 closed out — a net gain of 8 holders — while 6 added to existing stakes and 0 trimmed.

The largest buyer was Sio Capital Management, opening a new position worth an estimated $647K. The largest seller was BlackRock, exiting entirely with an estimated $12K sold.

  • 20 institutional investors held Bionano Genomics (BNGO) as of Q2 2020, up from 12 in Q1 2020.
  • Funds reported $1.98M of Bionano Genomics stock for Q2 2020, up 311% quarter-over-quarter.
  • 10 funds opened new Bionano Genomics positions in Q2 2020 and 2 closed out, a net change of +8 holders.
  • The largest Bionano Genomics buyer in Q2 2020 was Sio Capital Management, an estimated $647K added.
  • The largest Bionano Genomics seller in Q2 2020 was BlackRock, an estimated $12K sold.

Based on aggregated 13F filings for Q2 2020.